Outcomes | No. of studies | IR(95%CI) | Heterogeneity test | P-sub | |
---|---|---|---|---|---|
P I2 (%) | |||||
Overall | 30 | 0.384 (0.320, 0.447) | < 0.001 | 98.169 | – |
Location | Â | Â | Â | Â | 0.291 |
 Asia | 9 | 0.436 (0.319, 0.554) | < 0.001 | 97.477 |  |
 Western | 21 | 0.361 (0.287, 0.436) | < 0.001 | 98.268 |  |
Type of surgery | Â | Â | Â | Â | 0.694 |
 CS for CHD | 16 | 0.397 (0.324, 0.471) | < 0.001 | 98.024 |  |
 CS for CHD with CPB | 14 | 0.368 (0.242, 0.494) | < 0.001 | 98.343 |  |
Type of cohort | Â | Â | Â | Â | 0.118 |
 Prospective | 10 | 0.451 (0.352, 0.550) | < 0.001 | 95.038 |  |
 Retrospective | 20 | 0.352 (0.376, 0.427) | < 0.001 | 98.446 |  |
Age | Â | Â | Â | Â | 0.002 |
  < 1 month | 6 | 0.543 (0.452, 0.633) | 0.002 | 73.164 |  |
 1 month-18 years | 14 | 0.416 (0.335, 0.496) | < 0.001 | 96.927 |  |
  < 18 years | 10 | 0.299 (0.209, 0.389) | < 0.001 | 97.854 |  |
  ≥ 18 years | 3 | 0.300 (0.096, 0.505) | – | – |  |
Criteria of AKI | Â | Â | Â | Â | 0.471 |
 pRIFLE | 13 | 0.362 (0.255, 0.470) | < 0.001 | 98.584 |  |
 AKIN | 8 | 0.348 (0.242, 0.453) | < 0.001 | 96.643 |  |
 KDIGO | 9 | 0.447 (0.318, 0.576) | < 0.001 | 98.358 |  |